Developer docs
API playgroundTry for free, no card

Search company profiles

everlywell-us-tx

Full company profile

uuid02mitbk

Namestring
everlywell-us-tx
Legal namestring
Everly Health, Inc.
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Everlywell, operating under the legal entity Everly Health, Inc., is a privately held at-home health testing platform headquartered in Austin, Texas. Founded in 2015, the company sells direct-to-consumer diagnostic test kits spanning infectious disease, hormones, nutrition, gut health, sexual health, and reproductive health, with individual kit prices ranging from approximately $49 to $3,500. The company has expanded beyond a pure test-kit retailer into an integrated vertical stack that includes PWNHealth (physician oversight), Everly Diagnostics, PWN Remote Care Services and Everly Provider Group (telehealth provider networks), and PWN Laboratory. It has also added subscription offerings (Everlywell 360, Everlywell+, Weight Care+) and has acquired Natalist to extend its reproductive health line.

The platform monetizes through direct e-commerce test-kit sales, recurring subscription memberships, partner/marketplace transactions with third-party diagnostics providers (GRAIL for Galleri multi-cancer screening, Caris Life Sciences, Visby Medical, Quest Diagnostics), and integrated telehealth services — most recently including GLP-1 medication access via Weight Care+. Operationally, the company relies on HIPAA-compliant data handling, CLIA-certified lab partnerships, and LegitScript certification, with its owned provider entities enabling physician-ordered testing in more than 35 states.

The strategic posture is that of a consumer-facing diagnostics aggregator moving toward a full-stack testing-to-treatment platform. AI capability is currently limited to a featured component (Jona's AI-powered gut microbiome recommendations) rather than core infrastructure. Revenue mechanics are diversified across price points and subscription tiers, but customer concentration is structurally low given the absence of enterprise anchor accounts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home lab testing, direct-to-consumer diagnostics, telehealth consultations, biomarker health monitoring, food sensitivity testing
Industry3 codes
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
At-Home Diagnostic Testing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Direct test kit sales
TypeOne Time License
Description

One-time purchase of individual at-home test kits ranging from $49 to $3,500. Consumer pays upfront for sample collection kit, lab processing, and digital results.

everlywell.com
2Subscription memberships
TypeSubscription Recurring
Description

Recurring membership programs including Everlywell 360 (annual comprehensive testing) and Everlywell+ (monthly/annual credits for tests and products). Automatic renewal with recurring billing.

everlywell.com
3Virtual care / telehealth services
TypeProfessional Services
Description

Fee-based telehealth consultations with licensed practitioners for follow-up on abnormal results, prescription medications, and condition management.

everlywell.com
4Partner / marketplace multi-cancer screening tests
TypeTransaction Fee
Description

Distribution of premium multi-cancer early detection tests (Galleri at $949, Caris Detect at $3,500) as authorized reseller.

everlywell.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Marketing or Sales, Operations, Personnel, Supply Chain, Technology or R&D
Pricing details4 tiers
1Individual at-home test kits at various price points
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Cholesterol & Lipids Test: $49; Chlamydia & Gonorrhea Test: $69; Thyroid Test: $149; At-Home STD Test (5 infections): $169; Food Sensitivity Test: $199; Comprehensive Food Sensitivity Test: $299; Women's Health Test: $249; Men's Health Test: $249; Jona Gut Microbiome Test: $485; Galleri Multi-Cancer Screening: $949; Caris Detect Multi-Cancer Screening: $3,500

everlywell.com
2Everlywell 360 annual membership
ModelSubscriptionBilling cadenceAnnual
Notes

Annual comprehensive biomarker testing (83 biomarkers across 6 health categories) with automatic renewal. Membership fee charged yearly.

everlywell.com
3Everlywell+ monthly/annual membership
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly or annual credits for eligible services and products. Credits have no cash value and expire if unused.

everlywell.com
4Weight Care+ membership
ModelSubscriptionBilling cadenceMonthly
Notes

Paid weight management membership including virtual clinician visits and access to GLP-1 medications. First month included with Quest Weight Loss Journey Test Panel purchase, then recurring monthly billing.

everlywell.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Everlywell sells self-collection at-home diagnostic test kits (blood, saliva, urine, stool) that are mailed to consumers, registered online, and processed through a CLIA-certified lab partner network, with results delivered through a digital platform and follow-up telehealth consultations available for abnormal findings. Offerings span daily health (cholesterol, thyroid, vitamins), digestive health (food sensitivity, gut microbiome), sexual health (chlamydia, gonorrhea, multi-STI, rapid PCR), hormone health (women's, men's), and multi-cancer screening (Galleri, Caris Detect, FIT), available individually or through annual/recurring subscription memberships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 86% of cancers not caught by recommended screenings, detectable with multi-cancer early detection tests
+3 more records
Product overview1 text field

Everlywell is an innovative at-home health testing platform offering a comprehensive portfolio of diagnostic tests across multiple health categories. The core offering consists of direct-to-consumer lab tests for food sensitivity, sexual health, hormone health, thyroid function, cholesterol, and multi-cancer screening, sold individually and through subscription memberships (Everlywell 360, Everlywell+, and Weight Care+). The platform also includes virtual care telehealth services for consultations and prescriptions. Key products include the Food Sensitivity Test ($199), Comprehensive Food Sensitivity Test ($299), Women's Health Test ($249), Men's Health Test ($249), various STD tests ($69-$169), the Galleri Multi-Cancer test ($949), and Everlywell 360 (83-biomarker comprehensive testing). The Jona Gut Microbiome Test offers AI-powered diet recommendations. Tests are available as at-home collection kits with sample registration at results.everlywell.com, and certain tests (like Caris Detect) require in-person lab visits at Quest Diagnostics locations.

Product and service17 records
1Food Sensitivity Test
CategoryAt-home diagnostic test kit
Description

At-home test that measures IgG antibody reactivity to 96 foods to help identify food sensitivities, intended for individuals experiencing digestive or mystery symptoms.

2Comprehensive Food Sensitivity Test
CategoryAt-home diagnostic test kit
Description

Expanded at-home food sensitivity panel covering more food items than the standard Food Sensitivity Test.

3Women's Health Test
CategoryAt-home diagnostic test kit
Description

At-home test measuring 11 key biomarkers important for women's overall health, including hormones, for women tracking energy, mood, or reproductive symptoms.

4Men's Health Test
CategoryAt-home diagnostic test kit
Description

At-home hormone and wellness test designed specifically for men's health markers.

5Cholesterol & Lipids Test
CategoryAt-home diagnostic test kit
Description

At-home heart health panel measuring cholesterol and lipid levels, intended for consumers monitoring cardiovascular risk.

6Thyroid Test
CategoryAt-home diagnostic test kit
Description

At-home test for assessing thyroid function and health, targeted at individuals with fatigue, weight, or metabolic symptoms.

7At-Home STD Test
CategoryAt-home diagnostic test kit
Description

Confidential at-home screening for 5 common sexually transmitted infections, including Chlamydia, Gonorrhea, Hepatitis C, Syphilis, and Trichomoniasis, with same-day virtual treatment available.

8Chlamydia & Gonorrhea Test
CategoryAt-home diagnostic test kit
Description

Targeted at-home test for sexually transmitted infections Chlamydia and Gonorrhea.

9Visby Rapid PCR At-Home Female STD Test
CategoryAt-home diagnostic test kit
Description

Rapid PCR at-home test designed for women that detects 3 STIs with 98% accuracy and delivers results in under 30 minutes.

10Jona Gut Microbiome Test
CategoryAt-home diagnostic test kit
Description

At-home gut microbiome test providing insights on digestion, metabolism, and brain health, paired with AI-powered personalized diet and lifestyle recommendations.

11Galleri Multi-Cancer Early Detection Test
CategoryIn-person diagnostic screening test
Description

Blood-based screening test that can detect a signal shared by over 50 types of cancer before symptoms appear, distributed as an authorized reseller of GRAIL's Galleri test.

12Caris Detect Multi-Cancer Screening
CategoryIn-person diagnostic screening test
Description

Multi-cancer early detection test designed to identify cancers other tests may miss, offered as an in-person screening distributed from Caris Life Sciences.

13FIT Colon Cancer Screening Test
CategoryAt-home diagnostic test kit
Description

At-home fecal immunochemical test for early signs of colon cancer screening.

14Everlywell 360
CategoryAnnual testing membership
Description

Annual comprehensive at-home testing membership checking 83 biomarkers across six key health categories, with actionable digital results and free shipping, billed annually with automatic renewal.

15Everlywell+ Membership
CategorySubscription membership
Description

Paid membership providing monthly or annual credits redeemable for eligible Everlywell services and products, with credits having no cash value and expiring if unused.

16Weight Care+ Membership
CategorySubscription membership
Description

Paid weight management membership offering virtual visits with clinicians and access to prescription weight loss medications including GLP-1 medications, with the first month included upon purchase of the Quest Weight Loss Journey Test Panel.

17Virtual Care
CategoryTelehealth service
Description

Telehealth consultation and virtual healthcare service for various conditions including STI treatment, cold sores, and other health concerns, staffed by licensed practitioners affiliated with PWNHealth, PWN Remote Care Services, and Everly Provider Group.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

In-person sample collection at Quest Diagnostics Patient Service Centers for tests requiring physical visits. Available across multiple states including California, Texas, Florida, New York, and Pennsylvania. Appoints must be completed within 12 months of purchase.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Authorized reseller and distributor of the Galleri Multi-Cancer Early Detection Test, which can detect signals shared by over 50 types of cancer from a single blood draw. Everlywell charges $949 for this test.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Authorized reseller and distributor of the Caris Detect Multi-Cancer Screening test. Listed at $3,500 per test on Everlywell's platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partnership for the Visby Rapid PCR At-Home Female STD Test. Detects 3 STIs with 98% accuracy in under 30 minutes. Sold at $149.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliated telehealth and care provider networks. Independent licensed practitioners affiliated with these medical practices review test orders and provide telehealth consultations. Part of the Everly Health corporate family.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner entity referenced in navigation linking to everlyhealthsolutions.com. Part of the Everly Health corporate ecosystem of health solutions.

7Affiliate / Marketing Partners
Strategic tierMinorTypeGTM or Marketing Partner
Description

Everlywell operates an affiliate marketing program. Partners earn commissions for referring customers. Referenced in footer as 'Become an Affiliate' program.

everlywell.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct-to-consumer at-home lab testing company offering self-collection kits (sexual health, hormones, thyroid, cancer screening) with integrated telehealth and prescriptions. Operates its own CLIA-certified labs and shares Everlywell's full vertical model.

2Function Health
TypeDirect peer
Description

Membership-based comprehensive lab testing platform offering 100+ biomarkers annually with physician-reviewed results, directly mirroring the Everlywell 360 positioning with a sharper preventive-health framing.

TypeDirect peer
Description

D2C at-home STD and wellness testing company with mail-in sample collection and physician-reviewed results, overlapping Everlywell's sexual-health and broader self-test kit catalog.

TypeBroad incumbent
Description

Consumer-direct lab testing arm of Labcorp, one of the two largest clinical reference laboratories, offering self-ordered panels at retail-like price points with optional physician consults — competitive to Everlywell on price and breadth from an incumbent parent.

TypeBroad incumbent
Description

Direct-to-consumer arm of Quest Diagnostics, the largest US clinical lab, with self-ordered panels including sexual health, hormones, and general wellness — and the same in-person patient service center infrastructure Everlywell partners with for premium tests.

TypeDirect peer
Description

D2C personal genomics and health testing company with saliva-based kits and digital results, expanding into telehealth-adjacent offerings — a category peer in consumer health diagnostics with overlapping brand and e-commerce DNA.

TypeDirect peer
Description

D2C gut microbiome testing with AI-driven dietary and wellness recommendations, closely matching Everlywell's Jona gut microbiome test positioning and AI-personalization angle.

TypeDirect peer
Description

At-home health testing company covering hormone, heart, men's health and other biomarkers for consumers and enterprises, with physician-reviewed reporting — overlapping Everlywell's core wellness catalog.

TypeDirect peer
Description

D2C health and wellness brand combining at-home testing (including microbiome and aging biomarkers) with supplements and clinician-grade products, an adjacent peer at the intersection of testing and ongoing wellness subscriptions.

TypeBroad incumbent
Description

Public telehealth/D2C platform with subscription-driven recurring revenue across sexual health, mental health, dermatology, and weight loss — directly competitive in the GLP-1 weight-care and sexual-health verticals Everlywell serves through Weight Care+ and its STD panels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

everlywell-us-tx

At-Home Diagnostic Testingeverlyhealth.com

What everlywell-us-tx does

Everlywell, operating under the legal entity Everly Health, Inc., is a privately held at-home health testing platform headquartered in Austin, Texas. Founded in 2015, the company sells direct-to-consumer diagnostic test kits spanning infectious disease, hormones, nutrition, gut health, sexual health, and reproductive health, with individual kit prices ranging from approximately $49 to $3,500. The company has expanded beyond a pure test-kit retailer into an integrated vertical stack that includes PWNHealth (physician oversight), Everly Diagnostics, PWN Remote Care Services and Everly Provider Group (telehealth provider networks), and PWN Laboratory. It has also added subscription offerings (Everlywell 360, Everlywell+, Weight Care+) and has acquired Natalist to extend its reproductive health line.

The platform monetizes through direct e-commerce test-kit sales, recurring subscription memberships, partner/marketplace transactions with third-party diagnostics providers (GRAIL for Galleri multi-cancer screening, Caris Life Sciences, Visby Medical, Quest Diagnostics), and integrated telehealth services — most recently including GLP-1 medication access via Weight Care+. Operationally, the company relies on HIPAA-compliant data handling, CLIA-certified lab partnerships, and LegitScript certification, with its owned provider entities enabling physician-ordered testing in more than 35 states.

The strategic posture is that of a consumer-facing diagnostics aggregator moving toward a full-stack testing-to-treatment platform. AI capability is currently limited to a featured component (Jona's AI-powered gut microbiome recommendations) rather than core infrastructure. Revenue mechanics are diversified across price points and subscription tiers, but customer concentration is structurally low given the absence of enterprise anchor accounts.

everlywell-us-tx firmographics

Firmographics
Name
everlywell-us-tx
Legal name
Everly Health, Inc.
Website
https://everlyhealth.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

everlywell-us-tx industry classification

Industry
Product category
At-Home Diagnostic Testing
NAICS
Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

Keywords

  • At-home lab testing
  • Direct-to-consumer diagnostics
  • Telehealth consultations
  • Biomarker health monitoring
  • Food sensitivity testing

Where everlywell-us-tx is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

everlywell-us-tx business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Marketing or Sales, Operations, Personnel, Supply Chain, Technology or R&D

Revenue model

  1. Direct test kit sales: One-time purchase of individual at-home test kits ranging from $49 to $3,500. Consumer pays upfront for sample collection kit, lab processing, and digital results.
  2. Subscription memberships: Recurring membership programs including Everlywell 360 (annual comprehensive testing) and Everlywell+ (monthly/annual credits for tests and products). Automatic renewal with recurring billing.
  3. Virtual care / telehealth services: Fee-based telehealth consultations with licensed practitioners for follow-up on abnormal results, prescription medications, and condition management.
  4. Partner / marketplace multi-cancer screening tests: Distribution of premium multi-cancer early detection tests (Galleri at $949, Caris Detect at $3,500) as authorized reseller.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual at-home test kits at various price points
SubscriptionAnnualEverlywell 360 annual membership
SubscriptionMonthlyEverlywell+ monthly/annual membership
SubscriptionMonthlyWeight Care+ membership

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

everlywell-us-tx product offering

Product offering

Core offering

Everlywell sells self-collection at-home diagnostic test kits (blood, saliva, urine, stool) that are mailed to consumers, registered online, and processed through a CLIA-certified lab partner network, with results delivered through a digital platform and follow-up telehealth consultations available for abnormal findings. Offerings span daily health (cholesterol, thyroid, vitamins), digestive health (food sensitivity, gut microbiome), sexual health (chlamydia, gonorrhea, multi-STI, rapid PCR), hormone health (women's, men's), and multi-cancer screening (Galleri, Caris Detect, FIT), available individually or through annual/recurring subscription memberships.

Product overview

Everlywell is an innovative at-home health testing platform offering a comprehensive portfolio of diagnostic tests across multiple health categories. The core offering consists of direct-to-consumer lab tests for food sensitivity, sexual health, hormone health, thyroid function, cholesterol, and multi-cancer screening, sold individually and through subscription memberships (Everlywell 360, Everlywell+, and Weight Care+). The platform also includes virtual care telehealth services for consultations and prescriptions. Key products include the Food Sensitivity Test ($199), Comprehensive Food Sensitivity Test ($299), Women's Health Test ($249), Men's Health Test ($249), various STD tests ($69-$169), the Galleri Multi-Cancer test ($949), and Everlywell 360 (83-biomarker comprehensive testing). The Jona Gut Microbiome Test offers AI-powered diet recommendations. Tests are available as at-home collection kits with sample registration at results.everlywell.com, and certain tests (like Caris Detect) require in-person lab visits at Quest Diagnostics locations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Food Sensitivity Test At-home test that measures IgG antibody reactivity to 96 foods to help identify food sensitivities, intended for individuals experiencing digestive or mystery symptoms.
  • Comprehensive Food Sensitivity Test Expanded at-home food sensitivity panel covering more food items than the standard Food Sensitivity Test.
  • Women's Health Test At-home test measuring 11 key biomarkers important for women's overall health, including hormones, for women tracking energy, mood, or reproductive symptoms.
  • Men's Health Test At-home hormone and wellness test designed specifically for men's health markers.
  • Cholesterol & Lipids Test At-home heart health panel measuring cholesterol and lipid levels, intended for consumers monitoring cardiovascular risk.
  • Thyroid Test At-home test for assessing thyroid function and health, targeted at individuals with fatigue, weight, or metabolic symptoms.
  • At-Home STD Test Confidential at-home screening for 5 common sexually transmitted infections, including Chlamydia, Gonorrhea, Hepatitis C, Syphilis, and Trichomoniasis, with same-day virtual treatment available.
  • Chlamydia & Gonorrhea Test Targeted at-home test for sexually transmitted infections Chlamydia and Gonorrhea.
  • Visby Rapid PCR At-Home Female STD Test Rapid PCR at-home test designed for women that detects 3 STIs with 98% accuracy and delivers results in under 30 minutes.
  • Jona Gut Microbiome Test At-home gut microbiome test providing insights on digestion, metabolism, and brain health, paired with AI-powered personalized diet and lifestyle recommendations.
  • Galleri Multi-Cancer Early Detection Test Blood-based screening test that can detect a signal shared by over 50 types of cancer before symptoms appear, distributed as an authorized reseller of GRAIL's Galleri test.
  • Caris Detect Multi-Cancer Screening Multi-cancer early detection test designed to identify cancers other tests may miss, offered as an in-person screening distributed from Caris Life Sciences.
  • FIT Colon Cancer Screening Test At-home fecal immunochemical test for early signs of colon cancer screening.
  • Everlywell 360 Annual comprehensive at-home testing membership checking 83 biomarkers across six key health categories, with actionable digital results and free shipping, billed annually with automatic renewal.
  • Everlywell+ Membership Paid membership providing monthly or annual credits redeemable for eligible Everlywell services and products, with credits having no cash value and expiring if unused.
  • Weight Care+ Membership Paid weight management membership offering virtual visits with clinicians and access to prescription weight loss medications including GLP-1 medications, with the first month included upon purchase of the Quest Weight Loss Journey Test Panel.
  • Virtual Care Telehealth consultation and virtual healthcare service for various conditions including STI treatment, cold sores, and other health concerns, staffed by licensed practitioners affiliated with PWNHealth, PWN Remote Care Services, and Everly Provider Group.

Quantifiable outcome

  • 86% of cancers not caught by recommended screenings, detectable with multi-cancer early detection tests
  • +3 more outcomes

Companies that use everlywell-us-tx

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles2 records

everlywell-us-tx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

everlywell-us-tx partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Quest Diagnostics (Patient Service Centers)coreChannel Partner/ Reseller/ DistributorIn-person sample collection at Quest Diagnostics Patient Service Centers for tests requiring physical visits. Available across multiple states including California, Texas, Florida, New York, and Pennsylvania. Appoints must be completed within 12 months of purchase.
  • GRAIL (Galleri test)coreChannel Partner/ Reseller/ DistributorAuthorized reseller and distributor of the Galleri Multi-Cancer Early Detection Test, which can detect signals shared by over 50 types of cancer from a single blood draw. Everlywell charges $949 for this test.
  • Caris Life Sciences (Caris Detect)coreChannel Partner/ Reseller/ DistributorAuthorized reseller and distributor of the Caris Detect Multi-Cancer Screening test. Listed at $3,500 per test on Everlywell's platform.
  • Visby Medical (Rapid PCR STD Test)coreChannel Partner/ Reseller/ DistributorDistribution partnership for the Visby Rapid PCR At-Home Female STD Test. Detects 3 STIs with 98% accuracy in under 30 minutes. Sold at $149.
  • PWNHealth / PWN Remote Care Services / Everly Provider GroupcoreStrategic or Co-development PartnerAffiliated telehealth and care provider networks. Independent licensed practitioners affiliated with these medical practices review test orders and provide telehealth consultations. Part of the Everly Health corporate family.
  • Everly Health SolutionscoreStrategic or Co-development PartnerPartner entity referenced in navigation linking to everlyhealthsolutions.com. Part of the Everly Health corporate ecosystem of health solutions.
  • Affiliate / Marketing PartnersminorGTM or Marketing PartnerEverlywell operates an affiliate marketing program. Partners earn commissions for referring customers. Referenced in footer as 'Become an Affiliate' program.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

everlywell-us-tx competitors and assessment

Company assessment

Direct peers

  • LetsGetChecked: Direct-to-consumer at-home lab testing company offering self-collection kits (sexual health, hormones, thyroid, cancer screening) with integrated telehealth and prescriptions. Operates its own CLIA-certified labs and shares Everlywell's full vertical model.
  • Function Health: Membership-based comprehensive lab testing platform offering 100+ biomarkers annually with physician-reviewed results, directly mirroring the Everlywell 360 positioning with a sharper preventive-health framing.
  • myLab Box: D2C at-home STD and wellness testing company with mail-in sample collection and physician-reviewed results, overlapping Everlywell's sexual-health and broader self-test kit catalog.
  • 23andMe: D2C personal genomics and health testing company with saliva-based kits and digital results, expanding into telehealth-adjacent offerings — a category peer in consumer health diagnostics with overlapping brand and e-commerce DNA.
  • Viome: D2C gut microbiome testing with AI-driven dietary and wellness recommendations, closely matching Everlywell's Jona gut microbiome test positioning and AI-personalization angle.
  • imaware: At-home health testing company covering hormone, heart, men's health and other biomarkers for consumers and enterprises, with physician-reviewed reporting — overlapping Everlywell's core wellness catalog.
  • Thorne: D2C health and wellness brand combining at-home testing (including microbiome and aging biomarkers) with supplements and clinician-grade products, an adjacent peer at the intersection of testing and ongoing wellness subscriptions.

Broad incumbents

  • Labcorp OnDemand: Consumer-direct lab testing arm of Labcorp, one of the two largest clinical reference laboratories, offering self-ordered panels at retail-like price points with optional physician consults — competitive to Everlywell on price and breadth from an incumbent parent.
  • Quest Diagnostics (Direct-to-Consumer): Direct-to-consumer arm of Quest Diagnostics, the largest US clinical lab, with self-ordered panels including sexual health, hormones, and general wellness — and the same in-person patient service center infrastructure Everlywell partners with for premium tests.
  • Hims & Hers Health: Public telehealth/D2C platform with subscription-driven recurring revenue across sexual health, mental health, dermatology, and weight loss — directly competitive in the GLP-1 weight-care and sexual-health verticals Everlywell serves through Weight Care+ and its STD panels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

everlywell-us-tx social profiles

Digital presence

everlywell-us-tx compliance and trust

Trust signal

Compliance6 records

everlywell-us-tx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

everlywell-us-tx leadership team

Management profile

Number of profiles

Profiles1 record

everlywell-us-tx subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

everlywell-us-tx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

everlywell-us-tx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about everlywell-us-tx

What does everlywell-us-tx do?

Everlywell sells self-collection at-home diagnostic test kits (blood, saliva, urine, stool) that are mailed to consumers, registered online, and processed through a CLIA-certified lab partner network, with results delivered through a digital platform and follow-up telehealth consultations available for abnormal findings. Offerings span daily health (cholesterol, thyroid, vitamins), digestive health (food sensitivity, gut microbiome), sexual health (chlamydia, gonorrhea, multi-STI, rapid PCR), hormone health (women's, men's), and multi-cancer screening (Galleri, Caris Detect, FIT), available individually or through annual/recurring subscription memberships.

Is everlywell-us-tx a public or private company?

everlywell-us-tx is a private company. It is classified as venture growth investor backed and is currently operating.

When was everlywell-us-tx founded?

everlywell-us-tx was founded in 2015. It employs 251 to 500 people.

Where is everlywell-us-tx based?

everlywell-us-tx is headquartered in Austin, United States, in the North America region.

How does everlywell-us-tx make money?

Four revenue lines are on record. Direct test kit sales are the primary driver. The others are subscription memberships, virtual care / telehealth services and partner / marketplace multi-cancer screening tests.

Who are everlywell-us-tx's main competitors?

Direct peers on record are LetsGetChecked, Function Health, myLab Box, 23andMe, Viome, imaware and Thorne. Broad incumbents are Labcorp OnDemand, Quest Diagnostics (Direct-to-Consumer) and Hims & Hers Health.

Does everlywell-us-tx have an API?

No public API is recorded for everlywell-us-tx.

What industry is everlywell-us-tx in?

everlywell-us-tx's product category is At-Home Diagnostic Testing. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care, with a secondary code of HLAIADAO, Home Diagnostic & Self-Test OTC Kits. Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mpo-magSpot Check: A Discussion of the In-Vitro Diagnostics MarketThe in-vitro diagnostics market is expanding with home testing, as the FDA has cleared about 1,200 OTC IVDs since 1977. Everly Health launched a kidney health test in December 2023, and experts cite trends like point-of-care testing and sustainability challenges.Business InsiderThe 15 billion-dollar healthcare startups facing a make-or-break year in 2023Fifteen healthcare startups with valuations from $3.3 billion to $15.15 billion are profiled, including Komodo Health, Everly Health, and Tempus Labs. The list details their funding rounds, layoffs, and strategic moves, such as Komodo pausing its IPO and Ro cutting 18% of staff.Tampa Bay TimesCompanies rush to market at-home STD tests. But are they reliable?The FDA has not approved at-home STD test kits for use outside medical settings, despite growing consumer demand. CDC data shows nearly 2.5 million reported cases of chlamydia, gonorrhea, and syphilis in 2021, and experts urge approval to expand testing. Companies like CVS and Everly Health are selling kits, but regulators cite reliability concerns.Business Wire BlogEverly Health Unveils Spotwell™ Technology in New Mobile AppEverly Health launched its first iOS app, Everlywell, featuring Spotwell™ machine vision to validate blood samples in real time. The app, available since August, has nearly 30,000 downloads with a 4.9-star rating. It supports the full Everlywell testing suite with reminders and result access.AxiosHealth Tech: Everly's M&A driversEverly Health CEO Julia Cheek said the company's acquisition spree was driven by the convergence of telehealth, mail-order pharmacy, and home testing. The Austin-based firm, valued at $2.9 billion in March 2021, acquired PWNHealth, Home Access Health, and Natalist, and its women's health arm grew 300-400% year-over-year since 2020.AxiosEverly partnership to offer early-detection home cancer testsEverly Health is partnering with a home cancer testing company to offer its early-detection test to employer health plan members. The deal tests Everly's new enterprise division, Everly Health Solutions, which could target large employee pools. The company is valued at $2.9 billion and saw 300% revenue growth in 2021.AxiosHealth Tech: Everly's B2B moveEverly Health is partnering with a home cancer testing company to offer its early-detection test to employer health plans. The deal tests its new B2B division, Everly Health Solutions, which could target large employee pools. The company is valued at $2.9 billion and saw 300% revenue growth in 2021.CNBCThe at-home testing industry, from Covid to cancer, may be worth over $2 billion by 2025The at-home testing market may exceed $2 billion by 2025, according to Quest Diagnostics. Everly Health reported over 100% growth in 2021, and Modern Fertility offers fertility testing after a $1,500 bill. The market includes wellness tests that do not diagnose conditions.STATAmid a health tech consolidation wave, Everly Health acquires fertility startup NatalistEverly Health acquired fertility startup Natalist in an all-cash deal, adding women's and family services to its home testing lineup. Financial terms were not disclosed, and the acquisition follows similar moves by other telehealth companies.PR NewswireEverly Health Accelerates Position as Leading Digital Health Company with Acquisition of Women's Health Brand NatalistEverly Health acquired Natalist, a women's health brand offering conception and pregnancy essentials, in an all-cash deal with undisclosed terms. Natalist, which has grown from 300 to nearly 6,000 brick-and-mortar locations, will join Everly Health's portfolio of four subsidiaries.